Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial.
Saved in:
| Title: | Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial. |
|---|---|
| Authors: | Folkert IW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mehran R; Department of Thoracic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sun R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morris VK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Overman MJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kee B; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Antonoff MB; Department of Thoracic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tzeng CW; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dasari A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tran Cao H; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Parseghian CM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vilar E; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Willis J; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Newhook TE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hofstetter W; Department of Thoracic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kopetz SE; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Vauthey JN; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chun YS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. yschun@mdanderson.org. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2026 Apr; Vol. 33 (4), pp. 2899-2907. Date of Electronic Publication: 2025 Dec 10. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
